申请人:Hoffman-La Roche Inc.
公开号:US06610846B1
公开(公告)日:2003-08-26
2,3-Di-substituted N-heteroaromatic propionamides with said substitution at the 3-position being a substituted phenyl group and at the 2-position being a methyl cycloalkyl ring, said propionamides being glucokinase activators which increase insulin secretion in the treatment of type II diabetes.
2,3-二取代N-杂环丙酰胺,其中3位取代为取代苯基,2位取代为甲基环烷基环,这些丙酰胺是葡萄糖激酶激活剂,可增加胰岛素分泌,用于治疗2型糖尿病。